Why the study?
Does angiopoietin-related growth factor (AGF) enhance blood flow and angiogenesis in a mouse hind-limb ischemia model?
Population
Mouse hind-limb ischemia model and human umbilical venous endothelial cells
Comparison
Intramuscular injection of adenovirus harboring… vs Mice receiving NOS inhibitor L-NAME, eNOS…
Design
Preclinical
Authors
Loading...
AGF merits further preclinical testing for ischemic disease; leaves open translation to human peripheral artery disease therapy.
Does angiopoietin-related growth factor (AGF) enhance blood flow and angiogenesis in a mouse hind-limb ischemia model?
AGF enhances blood flow and promotes angiogenesis in ischemic tissue via the ERK1/2-eNOS-NO signaling pathway, highlighting its potential as a therapeutic target for ischemic vascular diseases.
Urano et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: